Neurosurgeon Chengyuan Wu, MD, MSBmE, Joins the Actuated Medical Advisory Board

BELLEFONTE, Pa. - Rezul -- Actuated Medical is pleased to announce that Dr. Chengyuan Wu has joined its Medical Advisory Board. A renowned expert in Stereotactic and Functional Neurosurgery, Dr. Wu currently serves as Professor of Neurosurgery and Radiology and the Chief of the Division of Epilepsy and Neuromodulation Neurosurgery (EN2) at Thomas Jefferson University in Philadelphia. He earned his Doctor of Medicine degree from Tufts University School of Medicine.

"We are thrilled to welcome Dr. Wu to our Medical Advisory Board. His expertise in deep brain implants and neurological treatments will be critical in guiding Actuated Medical's strategic focus over the next five years as we develop transformative tools for brain access, delivery, and performance. Dr. Wu's insights will help us address key challenges faced by neurosurgeons.  His contribution will shape our innovations and ensure we remain at the forefront of neurological healthcare advancements," said Maureen L. Mulvihill, Ph.D., President & CEO of Actuated Medical.

More on Rezul News

• Poolvillas Expands Local Presence on the Costa Blanca with New Offices in Moraira and Denia – Over 30 Years of Expertise Now Even Closer to Guests
• West Hive Capital Sells So Cal Retail Center for $24.5 Million
• Radarsign Redefines Crosswalk Safety with Launch of CrossCommand™ RRFB Crosswalk
• OpenSSL Corporation Opens 2026 Advisory Committees' Elections: Shape the Future!
• Steve Everett Jr. Named President of L.T. Hampel Corporation

"Joining the Actuated Medical team as a member of the Medical Advisory Board is an exciting opportunity. I look forward to collaborating with the talented team to develop innovative solutions that can improve minimally-invasive surgical methods and patient outcomes in neurotherapeutic procedures," said Chengyuan Wu, MD, MSBmE.

About Actuated Medical, Inc.

Actuated Medical is a medical technology innovator that is pioneering motion-based solutions to address critical, unmet clinical needs in gastroenterology and neurology. The team is committed to delivering transformative products that empower healthcare professionals to achieve greater precision, enhance efficiency, and drive better patient outcomes while reducing healthcare costs. The company's technologies are backed by a strategic path to commercialization with multiple exit opportunities, supported by invaluable feedback from industry leaders. Actuated holds 45 issued U.S. and international patents, 9 FDA 510(k) clearances, 5 Investigational Device Exemptions (IDEs), 33 pre-submissions, and has completed or is conducting 8 clinical studies. Actuated has been honored with two Small Business Administration (SBA) Tibbetts Awards for SBIR commercialization excellence (2014 & 2020).  Actuated operates out of a state-of-the-art 20,000 sq. ft. facility in central Pennsylvania and is certified with ISO 13485 and as a Woman-Owned Small Business (WOSB), reflecting its steadfast commitment to quality and innovation.

More on Rezul News

• Acuvance Acquires ROI Healthcare Solutions, Building a Dedicated Healthcare ERP Practice
• Max Tucci Award-Winning Media Powerhouse Launches New Podcast —Executive Produced by Emmy-Winning Daytime Icons Suzanne Bass & Fran Brescia Coniglio
• MILBERT.ai Brings Real Time Session Defense to Google Workspace and Google Cloud
• Cresa Joins Texas Advisory Services as a Strategic Partner
• Diversified Roofing Solutions Strengthens Presence as Leading Roofing Company in West Palm Beach

###

For media inquiries, please contact Maureen L. Mulvihill, Ph.D. by phone at 814-355-0003 or email at info@actuatedmedical.com.

Additional information can be found by visiting:

https://actuatedmedical.com/
https://actuatedneuroscience.com/